13. Comparison of Surgical Excision with Botulinum Toxin (Botox) Injection for Treatment of Hidradenitis Suppurativa in Axillary Region
Muhammad Usman1, Seemab Khan2 and Muhammad Saad Faisal3
ABSTRACT
Objective: To compare the outcome of surgical excision with botulin toxin injection for treatment of hidradenitis suppurativa in the axillary region was the objective of this study.
Study design: Randomized controlled trial study.
Place and Duration of Study: The study was conducted in Department of Plastic Surgery and Dermatology, Bakhtawar Amin Teaching and Trust Hospital, Multan from July, 2017 to July 2018.
Materials and Methods: Fifty patients with diagnosis of hideradinitis suppurativa in axillary region were included for clinical trial. The patietns were randomly allocated in two equal groups (25 patients in each gorup). The patiens in surgery group underwent surgical excision and in botulinum toxin injection grup received treatmetn with botulimun toxin injection with an interval of hidradenitis suppurativa. The patients were followed up for 6 months for outcome parameters i.e. recurrence of disease and patient satisfaction after both procedures.
Results: Mean age of the patients with Hidradenitis suppurativa were 28.69±5.61 and 29.11±5.17 years in surgery group and botulin toxin group. There were 18 (72.0%) males and 7 (28.0%) females in surgery group and 19 males 9 (76.0%) males and 6 (24.0%) females in botulinum toxin group. Overall recurrence was 4.0% after and 12.0% after surgical wide excision and Botulin Toxin Injection, respectively. The overall patient satisfaction was 88.0% with Botulin Toxin Injection treatment and 76.0% with surgical excision.
Conclusions: Surgical wide excision of hidradenitis suppurativa was found superior to Botulin toxin injection treatment in terms of recurrence and patient satisfaction.
Key Words: Hidradenitis suppurativa; Surgical wide excision; Botulin toxin injection
Citation of article: Usman M, Khan S, Faisal MS. Comparison of Surgical Excision with Botulinum
Toxin (Botox) Injection for Treatment of Hidradenitis Suppurativa in Axillary Region. Med Forum 2019;30(12):55-58.